Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04577807
Title PVSRIPO With or Without Immune Checkpoint Blockade in Patients With Advanced PD-1 Refractory Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Istari Oncology, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Research Institute Scottsdale Arizona 85258 United States Details
Orlando Health U7 Health Cancer Center Orlando Florida 32806 United States Details
Rush University Medical Center Chicago Illinois 60612 United States Details
Cancer Treatment Centers of America Zion Illinois 60099 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Henry Ford Health System Detroit Michigan 48208 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
University of Pittsburgh Hillman Cancer Center Pittsburgh Pennsylvania 15213 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
Texas Oncology -Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
Virginia Commonwealth University Richmond Virginia 23298 United States Details
West Virginia University Medical Center Morgantown West Virginia 26506 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field